Literature DB >> 29098818

[Advanced progress of main pharmacology activities of triptolide].

Jin Cui1, Xiao Chen1, Jia-Can Su1.   

Abstract

Triptolide is an active component in traditional Chinese medicine Tripterygium wilfordii. Currently, triptolide has been used to treat various diseases, including lupus, cancer, rheumatoid arthritis and nephritic syndrome. Its main pharmacology efficacies include anti-inflammation, anti-tumor, and immunity suppression. Recent studies have also demonstrated triptolide's protective effect on cardiovascular diseases and osteoporosis. This paper summarizes the pharmacological efficacy of triptolide based on the advance in studies of triptolide. Copyright© by the Chinese Pharmaceutical Association.

Entities:  

Keywords:  inflammation ; osteoporosis ; pharmacological activity ; triptolide ; tumor

Mesh:

Substances:

Year:  2017        PMID: 29098818     DOI: 10.19540/j.cnki.cjcmm.20170609.011

Source DB:  PubMed          Journal:  Zhongguo Zhong Yao Za Zhi        ISSN: 1001-5302


  4 in total

Review 1.  Research Progress of Traditional Chinese Medicine in Treatment of Myocardial fibrosis.

Authors:  Chunzhen Ren; Kai Liu; Xinke Zhao; Huan Guo; Yali Luo; Juan Chang; Xiang Gao; Xinfang Lv; Xiaodong Zhi; Xue Wu; Hugang Jiang; Qilin Chen; Yingdong Li
Journal:  Front Pharmacol       Date:  2022-06-08       Impact factor: 5.988

2.  Development of Triptolide Self-Microemulsifying Drug Delivery System and Its Anti-tumor Effect on Gastric Cancer Xenografts.

Authors:  Minghua Xie; Jia Wu; Liqaing Ji; Xiaorui Jiang; Jin Zhang; Min Ge; Xinjun Cai
Journal:  Front Oncol       Date:  2019-10-03       Impact factor: 6.244

Review 3.  Ganglioside GD3 synthase (GD3S), a novel cancer drug target.

Authors:  Jinyi Liu; Xiangjin Zheng; Xiaocong Pang; Li Li; Jinhua Wang; Cui Yang; Guanhua Du
Journal:  Acta Pharm Sin B       Date:  2018-07-25       Impact factor: 11.413

4.  Triptonide inhibits metastasis potential of thyroid cancer cells via astrocyte elevated gene-1.

Authors:  Liangjie Fu; Xiaohong Niu; Ruhui Jin; Feiyun Xu; Jiguo Ding; Li Zhang; Zihui Huang
Journal:  Transl Cancer Res       Date:  2020-02       Impact factor: 1.241

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.